Time and Labour Saving Assay to Identify Paracetamol Overdose

Laboratory products

Time and Labour Saving Assay to Identify Paracetamol Overdose

14 Jan, 2011

Published over 15 years ago. See the latest and most current information on Laboratory products.

The Roche Acetaminophen (Paracetamol) 10 minutes-to-result assay is an easy to use and effective low-cost method for laboratories to incorporate into their routine

testing menu. The assay is easily incorporated onto a Roche platform, which combined with ready-to-use reagents, ensures time and labour savings. Additionally, the

2-shot assay has no interference with the Paracetemol Antidode N-Acetylcysteine, making it extremely reliable for consistent patient follow-up. Acetaminophen is a

common drug used in many formulations due to its analgesic and antipyretic properties and chronic excessive use of acetaminophen can result in hepatotoxicity and

nephrotoxicity. Overdosage of acetaminophen can lead to severe hepatic damage and, if left untreated to hepatic failure. Early diagnosis of acetaminophen induced

hepatotoxicity is vitally important – studies have shown that initiation of therapy within 16 hours of ingestion lessens the potential for hepatic injury and decreases the

mortality rate. Laboratories using the Roche Acetaminophen assay can provide rapid (10 minutes-to-result) and accurate quantitative determination of acetaminophen

in human serum or plasma, allowing clinicians to instigate therapy at the earliest, potentially life-saving, opportunity. The many assay benefits include: excellent interand intra-assay precision for safe and reliable results and consistency in patient follow-up; superior on-board stability for optimal reagent efficiency (even at only 1

sample per day); calibration curve stability; high sensitivity (≤1.2 μg/ml depending on the platform in use) and precision (≤ 2.0% CV on cobas® series and MODULAR

ANALYTICS platforms; ≤ 5.8% CV on INTEGRA® platforms). Roche has one of the most complete critical care portfolios and the most complete therapeutic drug

monitoring (TDM) menu available on a single platform. By consolidating critical care and TDM assays in this way, laboratory testing processes and workflow efficiency

can be optimised to achieve significant time, labour and cost savings.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Instrumentation built for AMP8 and beyond
Explore more Arrow
Pollution Solutions Online
Keeping ballast water compliance on course
Explore more Arrow
Petro Online
Digitalisation advances at a large petrochemical complex in China
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow